"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Relationship of time to relapse (TTR) and survival post relapse (SPR): Exploration of risk factors from the first annual follow-up data set of randomized pbo-controlled study of oregovomab (OV) as a ...
A large retrospective analysis of real-world data is shedding a bright light on the value of pelvic lymph node irradiation (PLNI) in patients with muscle-invasive bladder cancer (MIBC) undergoing ...
IT’S something we all do lots of this time of year – dismiss symptoms as ‘nothing to worry about’ or just a ‘bug’. But when ...
The therapeutic benefit of extended pelvic lymph node dissection (ePLND) for patients with prostate cancer is uncertain. New data from a study by Firas Abdollah, Alberto Briganti and colleagues from ...
Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer Thirty percent of patients treated ...
Sentinel pelvic lymph node dissection is a radioisotope-guided technique that has been developed for the detection of potential lymph node metastases. In this Viewpoint, Professor Janetschek discusses ...
Preoperative (left; top and bottom) and postoperative PSMA-PET/CT images (right; top and bottom) demonstrate the successful removal of two positive pelvic lymph nodes in the radioguided surgical ...
Medically reviewed by Archana Sharma, DO Uterine cancer is staged using the FIGO and TNM systems based on tumor size, lymph ...
Whole pelvis radiation improves cancer-specific and overall survival in muscle-invasive bladder cancer compared to bladder-only radiation. Median cancer-specific survival was 84 months for whole ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback